ArticleJournal of translational medicine2015

Evaluation of in vivo responses of sorafenib therapy in a preclinical mouse model of PTEN-deficient of prostate cancer.

Yutaka Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.